Search results for "RICS"

showing 10 items of 14086 documents

Hormone therapy is associated with better body composition and adipokine/glucose profiles

2012

Objective: The aim of this study was to evaluate the possibility of preventing the metabolic health consequences of postmenopausal hypogonadism with the use of long-term hormone therapy (HT). Methods: We used a monozygotic co-twin control design including 10 twin pairs (aged 56-62 y) discordant for HT (duration of HT, 2-10 y). In addition, 14 premenopausal women (aged 29-35 y) who did not use HT were studied to evaluate the differences in metabolic health between the premenopausal and postmenopausal states. Body composition was determined, and waist-to-hip ratio was used as an estimate for fat distribution. Serum sex steroids, sex hormone-binding globulin, and serum lipid and glucose profil…

AdultBlood Glucosenaisetmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentkehon koostumusCo twin controlAdipose tissueAdipokineCarbohydrate metabolismAdipokinesSex Hormone-Binding GlobulinInternal medicineLeukocytesmedicineHumansRNA MessengerGonadal Steroid HormonesMuscle SkeletalChemokine CCL2kehonkoostumusMetabolic healthkaksostutkimusWaist-Hip Ratiobusiness.industryEstrogen Replacement TherapyadipokoinesObstetrics and Gynecologyta3141Twin studyTwins MonozygoticMiddle Agedadipokiinitmedicine.diseaseLipidsPostmenopauseMenopauseEndocrinologyAdipose TissuePremenopauseEstrogenCase-Control StudiesBody CompositionFemaleHormone therapyInsulin ResistancebusinessMenopause
researchProduct

A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), administered at two different dose schedules in patients with plati…

2004

OBJECTIVES: There is an urgent need for new agents with activity in platinum- and taxane-resistant epithelial ovarian cancer. Exatecan mesylate is a novel topoisomerase I inhibitor with potent activity against ovarian cancer in vitro. A multicentre phase IIA study was conducted in patients with platinum- and taxane-resistant epithelial ovarian cancer. PATIENTS AND METHODS: Fifty-seven patients with bidimensionally measurable ovarian cancer, previously exposed to platinum and taxanes, whose disease had relapsed within 6 months of platinum-containing chemotherapy were randomised to one of two intravenous schedules of exatecan mesylate; 0.3 mg/m(2) daily for 5 days every 3 weeks (Arm A) or 2.1…

AdultBridged-Ring Compoundsmedicine.medical_specialtyOrganoplatinum Compoundsmedicine.medical_treatmentPharmacologyNeutropeniaGastroenterologyDrug Administration Schedulechemistry.chemical_compoundRefractoryInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansExatecanEnzyme InhibitorsAgedOvarian NeoplasmsChemotherapyTaxanebusiness.industryObstetrics and GynecologyExatecan mesylateMiddle Agedmedicine.diseaseAntineoplastic Agents PhytogenicDrug Resistance MultipleRegimenOncologychemistryDrug Resistance NeoplasmCamptothecinFemaleTaxoidsTopoisomerase I InhibitorsbusinessOvarian cancer
researchProduct

The role of nesfatin and selected molecular factors in various types of endometrial cancer

2019

Objectives: Endometrial cancers (ECs) are the most common gynaecological cancers in well developed countries. Diabetes and metabolic syndrome are among the biggest risk factors. Nesfatin-1, the adipokine derivative of NUCB2 (nucleobindin derivative 2) is linked to the clinical course of EC. Molecular factors, including mutations in MLH1 and MHS2 genes, c-MET and ARID1A are also related to prognosis in endometrial cancer. Material and methods: Using sections of paraffin-embedded preparations and immunohistochemistry, the expression of NESF1, MLH1, MSH2,c-MET and ARID1A were examined. Results: In this study on protein expression, EC tissues manifested (although insignificantly) an elevated ex…

AdultC-MetARID1AAdipokineMLH1chemistry.chemical_compoundNESF-1Biomarkers TumormedicineHumansNucleobindinsc-METAgedRetrospective StudiesAged 80 and overbusiness.industryEndometrial cancerMLH1Obstetrics and GynecologyMiddle AgedPrognosismedicine.diseaseARID1AImmunohistochemistryMSH2Endometrial NeoplasmsDNA-Binding ProteinschemistryMSH2endometrial cancerCancer researchImmunohistochemistryFemaleMetabolic syndromebusinessTranscription FactorsGinekologia Polska
researchProduct

Cancer in children and adolescents in Europe: Developments over 20 years and future challengers

2006

This special issue contains 18 articles describing population-based analyses of incidence and survival for cancer among children and adolescents in Europe over the period 1978-1997. The analyses were derived from the large database of the ACCIS project (Automated Childhood Cancer Information System), which was built through collaboration of 62 population-based cancer registries in 19 European countries. Data on 88,465 cancers in children and 15,369 in adolescents (age 15-19 yrs) were included in the various analyses, making this the largest database on cancer in these age-groups in the world. National data were grouped into five European regions to allow comparisons of incidence and surviva…

AdultCancer ResearchPediatricsmedicine.medical_specialtycancer incidenceTime FactorsAdolescentDatabases FactualPopulationSDG 3 - Good Health and Well-beingNeoplasmsmedicineHumansRegistriesMortalityeducationChildeducation.field_of_studycancer incidence; Childhood cancers - survival - time trendsbusiness.industryPublic healthIncidence (epidemiology)IncidenceConfoundingInfant NewbornCancerInfantmedicine.diseaseSurvival AnalysisEuropeOncologyEl NiñoData qualityChild PreschoolEtiologybusinessChildhood cancers - survival - time trendsDemography
researchProduct

Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term obs…

2007

Abstract Background : Human papilloma virus (HPV) is one of the most frequently observed sexually transmitted infections. The study' purpose was to investigate the relation between a mother's gynecological history and the local status of her child with recurrent respiratory papillomatosis (RRP). Methods : Forty-two patients enrolled in a prospective multicenter study between 1983 and 1990. The study included patients with juvenile-onset and adult-onset RRP. All patients underwent surgery and treatment with α-interferon. Thirty-eight patients were followed up until 31.01.2006. Twenty-five mothers of these patients participated in a parallel prospective study of genital HPV infection. In 1989…

AdultCancer Researchmedicine.medical_specialtyAdolescentmedicine.medical_treatmentVaginal DiseasesPapillomatosisUterine Cervical DiseasesPregnancyRecurrenceRisk FactorsPrevalencemedicineHumansLongitudinal StudiesPregnancy Complications InfectiousChildProspective cohort studyReproductive HistoryAgedColposcopyGynecologyHysterectomyPapillomamedicine.diagnostic_testObstetricsbusiness.industryPapillomavirus InfectionsHPV infectionInfantMiddle AgedCondyloma AcuminatumHuman papillomavirus 6medicine.diseaseRespiratory Tract NeoplasmsKoilocyteOncologyChild PreschoolFemaleRecurrent Respiratory Papillomatosismedicine.symptombusinessCancer Detection and Prevention
researchProduct

Population attributable risk for ovarian cancer

2000

Parity, oral contraceptive (OC) use, age at menopause, a family history of the disease and selected aspects of diet have been related to the risk of ovarian cancer. The quantification of their impact on a population level may help focus and rank the importance of potential prevention strategies. Using data from a case-control study conducted in Italy between 1983 and 1991 on 971 ovarian cancer cases and 2758 control women we computed the multivariate relative risk estimates, and population attributable risks (PARs), i.e. the proportion of ovarian cancers that would have been avoided if a given exposure had not been present in the population. Overall, the PARs were 5% for nulliparity, 12% fo…

AdultCancer Researchmedicine.medical_specialtyEpidemiologyPopulationEpidemiology; Risk factors; WomenAge DistributionmedicineHumansWomenRisk factorFamily historyAge of OnseteducationMultivariate AnalysiAgedGynecologyOvarian Neoplasmseducation.field_of_studybusiness.industryObstetricsOvarian NeoplasmCase-control studyMiddle Agedmedicine.diseaseDietMenopauseParityOncologyItalyRisk factorsRelative riskCase-Control StudiesAttributable riskMultivariate AnalysisFemaleMenopauseCase-Control StudieOvarian cancerbusinessHumanContraceptives Oral
researchProduct

Comparative column chromatographic estimations of phenylalanine in plasma, whole blood, native and paper-dried capillary blood of healthy children an…

1984

The concentration of phenylalanine in plasma, whole venous and capillary blood, and paper-dried blood of 75 probands (25 healthy adults, 27 healthy children, and 23 patients with hyperphenylalaninaemia) were measured by use of a sensitive short column chromatography method. The comparison of the values in each group of probands by several statistic methods showed an excellent correlation of the phenylalanine concentration in paper-dried whole blood to those measured in venous plasma. Evaluation of the analytical method revealed a high sensitivity and accuracy by use of a sample volume of 50 microliter. We would therefore suggest that the estimation of phenylalanine for the diagnosis and the…

AdultCapillary actionPhenylalaninePhenylalanine030204 cardiovascular system & hematologyVeins03 medical and health sciences0302 clinical medicineHyperphenylalaninemiaColumn chromatographyPlasma/Whole bloodReference Values030225 pediatricsBlood plasmaGeneticsmedicineHumansChildAmino Acid Metabolism Inborn ErrorsGenetics (clinical)Whole bloodChromatographyChromatographyChemistryVenous PlasmaMiddle Agedmedicine.disease3. Good healthCapillariesChild PreschoolJournal of inherited metabolic disease
researchProduct

Protein aggregation in congenital myopathies.

2011

Protein aggregation in congenital myopathies may be encountered among different myofibrillar myopathies such as granulofilamentous myopathy, cytoplasmic body myopathy, or spheroid body myopathy, which are designated as αB crystallinopathy, desminopathy, and myotilinopathy, respectively, according to the respective mutant proteins. Caps in cap disease and reducing bodies in reducing body myopathy were disclosed to contain numerous proteins. The multitude of diverse proteins aggregating within muscle fibers suggests impaired extralysosomal degradation of proteins, a disturbance of catabolism. The lack of different proteins accruing, but the mutant ones at an early age of affected patients in …

AdultCatabolismMutantInfantProtein aggregationBiologySarcomereActinsDesminBiochemistryChild PreschoolPediatrics Perinatology and Child HealthMyosinMutationmedicineHumansMutant ProteinsNeurology (clinical)medicine.symptomMyopathyMyofibrilChildActinMyopathies Structural CongenitalSeminars in pediatric neurology
researchProduct

Immunohistochemical Investigation of Metastasis-Related Chemokines in Deep-Infiltrating Endometriosis and Compromised Pelvic Sentinel Lymph Nodes

2015

Endometriosis is a prevalent benign disease, despite sharing several similarities with malignancies, such as the possibility of lymphatic spread. In malignancies, chemokines play a sovereign role in the process of metastasis. Metastasis-related chemokine axes have not yet been assessed in deep-infiltrating endometriosis (DIE), and this investigation was the aim of our study. The expression of these chemokines was investigated by immunohistochemistry in rectovaginal DIE lesions and in matched pelvic sentinel lymph nodes (PSLNs) of patients with endometriosis (n = 27), and their expression in the eutopic endometrium (EE) of endometriosis-free women (n = 20) was used as controls. Their stainin…

AdultChemokinePathologymedicine.medical_specialtyEndometriosisEndometriosislymphatic spreadMetastasisEndometriumYoung AdultCell MovementLymphatic SpreadmedicineHumansEutopic endometriumpelvic sentinel lymph nodeRetrospective StudiesbiologySentinel Lymph Node Biopsybusiness.industrychemokineendometriosiObstetrics and GynecologyMiddle Agedmedicine.diseaseImmunohistochemistryDeep infiltrating endometriosisbiology.proteinImmunohistochemistryFemaleLymph NodesLymphChemokinesbusinessBiomarkersReproductive Sciences
researchProduct

Pregnancy in primary sclerosing cholangitis

2011

Background There is a paucity of data on fertility or pregnancy in patients with primary sclerosing cholangitis (PSC). Objective To assess fertility in PSC by comparing the number of children in a large cohort of PSC patients to healthy controls and to investigate the outcome of pregnancy, as well as the influence of pregnancy on the disease course. Design Case series. Setting Germany. Participants 229 PSC patients and 569 healthy controls were evaluated for the number of children. 17 patients with PSC and at least one pregnancy, or who received a diagnosis of PSC within 6 months after delivery, were included in the more detailed analysis. Main outcome measures Number of children per patien…

AdultCholagogues and Cholereticsmedicine.medical_specialtyTime FactorsAdolescentmedia_common.quotation_subjectCholangitis SclerosingFertilityAutoimmune hepatitisPrimary sclerosing cholangitisYoung AdultPregnancyRisk FactorsGermanyAzathioprinemedicineHumansYoung adultmedia_commonPregnancyFetusObstetricsbusiness.industryIncidenceIncidence (epidemiology)Ursodeoxycholic Aciddigestive oral and skin physiologyInfant NewbornPregnancy OutcomeGastroenterologymedicine.diseasedigestive system diseasesPregnancy ComplicationsImmunologyGestationFemalebusinessImmunosuppressive AgentsFollow-Up StudiesGut
researchProduct